Skip to content
healthcare.dev

Gemcitabine hydrochloride

NDC 82511-008, Gemcitabine hydrochloride, injection, powder, lyophilized, for solution, from Teyro Labs Private Limited.

Product NDC
82511-008
Status
Listed
Labeler
Teyro Labs Private Limited
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078759
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82511-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GEMCITABINE HYDROCHLORIDE200 mg/5mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
82511-008-20825110008201 VIAL, SINGLE-USE in 1 CARTON (82511-008-20) / 5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a6ddaa2f-4c17-430f-a7cd-96b6662923f6

Use it

Look up 82511-008 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82511-008 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82511-008. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.